KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Idexx Laboratories (IDXX) Short-Term Debt issuances (2020 - 2026)

Idexx Laboratories has reported Short-Term Debt issuances over the past 4 years, most recently at -$57.0 million for Q4 2025.

  • For Q4 2025, Short-Term Debt issuances changed N/A year-over-year to -$57.0 million; the TTM value through Dec 2025 reached $148.0 million, changed N/A, while the annual FY2025 figure was $148.0 million, N/A changed from the prior year.
  • Short-Term Debt issuances for Q4 2025 was -$57.0 million at Idexx Laboratories, up from -$124.0 million in the prior quarter.
  • Over five years, Short-Term Debt issuances peaked at $326.5 million in Q1 2022 and troughed at -$167.5 million in Q2 2023.
  • A 3-year average of $29.5 million and a median of -$14.0 million in 2023 define the central range for Short-Term Debt issuances.
  • On a YoY basis, Short-Term Debt issuances climbed as much as 145.18% in 2023 and fell as far as 179.38% in 2023.
  • Year by year, Short-Term Debt issuances stood at -$54.0 million in 2022, then soared by 74.07% to -$14.0 million in 2023, then plummeted by 307.14% to -$57.0 million in 2025.
  • Business Quant data shows Short-Term Debt issuances for IDXX at -$57.0 million in Q4 2025, -$124.0 million in Q3 2025, and $259.5 million in Q2 2025.